132.95 USD
-1.78 (-1.32%)
We assign a fundamental rating of 6 out of 10 to NHC. NHC was compared to 100 industry peers in the Health Care Providers & Services industry. While NHC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NHC is valued correctly, but it does not seem to be growing. Finally NHC also has an excellent dividend rating. These ratings could make NHC a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
In the past year NHC was profitable.
NHC had a positive operating cash flow in the past year.
NHC had positive earnings in each of the past 5 years.
In the past 5 years NHC always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.71%, NHC belongs to the top of the industry, outperforming 87.00% of the companies in the same industry.
With a decent Return On Equity value of 10.26%, NHC is doing good in the industry, outperforming 74.00% of the companies in the same industry.
NHC has a Return On Invested Capital of 6.69%. This is in the better half of the industry: NHC outperforms 67.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NHC is significantly below the industry average of 9.42%.
The last Return On Invested Capital (6.69%) for NHC is above the 3 year average (3.68%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROIC | 6.69% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
1.3 Margins
NHC's Profit Margin of 7.19% is amongst the best of the industry. NHC outperforms 86.00% of its industry peers.
In the last couple of years the Profit Margin of NHC has grown nicely.
The Operating Margin of NHC (7.99%) is better than 74.00% of its industry peers.
NHC's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 38.11%, NHC is doing good in the industry, outperforming 67.00% of the companies in the same industry.
NHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% |
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
2. Health
2.1 Basic Checks
NHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
NHC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NHC has more shares outstanding
NHC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.36 indicates that NHC is not in any danger for bankruptcy at the moment.
NHC's Altman-Z score of 4.36 is fine compared to the rest of the industry. NHC outperforms 79.00% of its industry peers.
NHC has a debt to FCF ratio of 0.93. This is a very positive value and a sign of high solvency as it would only need 0.93 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.93, NHC belongs to the top of the industry, outperforming 91.00% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that NHC is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, NHC is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Altman-Z | 4.36 |
ROIC/WACC0.78
WACC8.62%
2.3 Liquidity
A Current Ratio of 1.72 indicates that NHC should not have too much problems paying its short term obligations.
The Current ratio of NHC (1.72) is better than 68.00% of its industry peers.
NHC has a Quick Ratio of 1.69. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
NHC's Quick ratio of 1.69 is fine compared to the rest of the industry. NHC outperforms 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 13.19% over the past year.
NHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.03% yearly.
The Revenue has grown by 22.82% in the past year. This is a very strong growth!
Measured over the past years, NHC shows a small growth in Revenue. The Revenue has been growing by 5.58% on average per year.
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.81, the valuation of NHC can be described as rather expensive.
Based on the Price/Earnings ratio, NHC is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.49, NHC is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.81 | ||
| Fwd PE | N/A |
4.2 Price Multiples
NHC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NHC is cheaper than 68.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 69.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.35 | ||
| EV/EBITDA | 11.19 |
4.3 Compensation for Growth
NHC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.47
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NHC has a Yearly Dividend Yield of 1.87%.
Compared to an average industry Dividend Yield of 2.55, NHC pays a better dividend. On top of this NHC pays more dividend than 91.00% of the companies listed in the same industry.
NHC's Dividend Yield is comparable with the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.87% |
5.2 History
The dividend of NHC has a limited annual growth rate of 3.30%.
NHC has paid a dividend for at least 10 years, which is a reliable track record.
NHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
NHC pays out 35.96% of its income as dividend. This is a sustainable payout ratio.
The dividend of NHC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP35.96%
EPS Next 2YN/A
EPS Next 3YN/A
NYSEARCA:NHC (12/8/2025, 10:44:56 AM)
132.95
-1.78 (-1.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners62.45%
Inst Owner Change5.58%
Ins Owners7.08%
Ins Owner Change0.24%
Market Cap2.06B
Revenue(TTM)1.46B
Net Income(TTM)104.80M
Analysts60
Price TargetN/A
Short Float %2.42%
Short Ratio4.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.87% |
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP35.96%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.81 | ||
| Fwd PE | N/A | ||
| P/S | 1.42 | ||
| P/FCF | 17.35 | ||
| P/OCF | 13.84 | ||
| P/B | 2.02 | ||
| P/tB | 2.48 | ||
| EV/EBITDA | 11.19 |
EPS(TTM)6.71
EY5.05%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.66
FCFY5.76%
OCF(TTM)9.61
OCFY7.22%
SpS93.95
BVpS65.84
TBVpS53.58
PEG (NY)N/A
PEG (5Y)2.47
Graham Number99.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROCE | 9.01% | ||
| ROIC | 6.69% | ||
| ROICexc | 8.35% | ||
| ROICexgc | 10.23% | ||
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% | ||
| FCFM | 8.16% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score4
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Debt/EBITDA | 0.64 | ||
| Cap/Depr | 68.45% | ||
| Cap/Sales | 2.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.81% | ||
| Profit Quality | 113.47% | ||
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.36 |
F-Score4
WACC8.62%
ROIC/WACC0.78
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.08%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.85%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y136.11%
OCF growth 3Y19.81%
OCF growth 5Y1.4%
NATIONAL HEALTHCARE CORP / NHC FAQ
What is the fundamental rating for NHC stock?
ChartMill assigns a fundamental rating of 6 / 10 to NHC.
What is the valuation status of NATIONAL HEALTHCARE CORP (NHC) stock?
ChartMill assigns a valuation rating of 4 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Fairly Valued.
How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?
NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.
What are the PE and PB ratios of NATIONAL HEALTHCARE CORP (NHC) stock?
The Price/Earnings (PE) ratio for NATIONAL HEALTHCARE CORP (NHC) is 19.81 and the Price/Book (PB) ratio is 2.02.
How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?
The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 35.96%.